Developer docs
API playgroundTry for free, no card

Search company profiles

ResApp Health

Full company profile

uuid0005v99

Namestring
ResApp Health
Websiteurl
resapphealth.com.au
Company typeenum
Private
Founded yearint
1990
Descriptiontext

ResApp Health is an Australia-based digital healthcare company whose stated focus is developing software solutions to assist doctors, headquartered in Perth and previously listed on the Australian Securities Exchange under the ticker RAP. Founded in 1990 as a for-profit entity, it operated with a very lean team of 1–10 employees, suggesting a small, product-focused organization rather than a scaled commercial enterprise. The company's source material describes it in functional terms as a digital healthcare product developer, but does not include product-level descriptions, platform architecture, pricing, customer segments, or a defined go-to-market motion.

Capital activity is the most documented dimension of the company's operating history. ResApp closed three disclosed funding rounds: approximately AUD 3.09M in June 2015, AUD 9.74M in April 2016, and AUD 5.0M in February 2020 — a cumulative ~AUD 17.8M raise. No lead investors or round participants are identified in the source. Leadership comprises founder, CEO and Managing Director Tony Keating, Executive Director and Vice President Brian Leedman, and VP of Product and Technology Scott Savage.

The company's current operating footprint is markedly diminished. It is recorded as delisted from the ASX, and the corporate domain (resapphealth.com.au) returns a default cPanel error page indicating hosting or DNS issues rather than active content. No revenue figures, customer logos, product overviews, partnerships, regulatory milestones, M&A activity, or post-2020 strategic events are present in the source data. The information set is therefore better characterized as historical capital-record data rather than an active operating profile.

Short descriptiontext

ResApp Health is an Australia-based digital healthcare company developing solutions to assist doctors. Founded in 1990 in Perth, previously ASX-listed (RAP) and now delisted with a non-functional website; operated with a 1–10 person team.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPerth, Australia
HQ citystring
Perth
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Keyword5 values
digital health diagnostics, clinical decision support, respiratory diagnostics, healthcare mobile applications, medical software platforms
Industry2 codes
1Virtual Urgent Care & Triage Platforms
CodeHLALABABPrimaryYes
2Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
CodeHLALABAJPrimaryNo
NAICS code1 code
  • Software Publishers513210
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Digital Health Diagnostics
Cost components3 values
Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

ResApp Health is developing digital healthcare solutions to assist doctors. The company focuses on creating technology-based diagnostic and clinical support tools intended for use by medical professionals in patient care settings.

Differentiator
Functional benefit
Problem solved
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
1Ada Health
TypeDirect peer
Description

Ada Health develops AI-powered symptom assessment and triage tools for both consumers and clinicians. Highly comparable to ResApp in targeting doctor-adjacent, symptom/triage decision support via software-only delivery.

2Babylon Health
TypeDirect peer
Description

Babylon (acquired by eMed) built digital-first triage and virtual care tools used by clinicians and health systems. Comparable in providing software-led clinical decision support and triage to assist doctors, similar user workflow to ResApp's described offering.

3K Health
TypeDirect peer
Description

K Health provides AI-driven clinical decision support and virtual primary care, with both consumer-facing triage and clinician-facing workflows. Direct peer in physician-assist digital health tooling.

4Biofourmis
TypeEmerging player
Description

Biofourmis focuses on AI-driven remote monitoring and predictive analytics for clinicians, particularly respiratory and cardiac conditions. Comparable in clinician-facing digital diagnostics using AI/ML on physiological signals.

5Current Health (Best Buy Health)
TypeEmerging player
Description

Current Health offers a remote patient monitoring and care management platform used by health systems to support clinicians with patient triage and decision-making. Comparable as a digital health platform augmenting clinical workflows.

6Telehealth Medical (Doctor Anywhere / Doctor On Demand)
TypeBroad incumbent
Description

Doctor On Demand (now part of Included Health) provides direct virtual urgent care and primary care platforms with clinician workflow tools. Comparable as a virtual triage / urgent care platform serving clinicians and patients.

7Teladoc Health
TypeBroad incumbent
Description

Teladoc Health is the largest virtual care platform with provider-grade triage and decision support baked into its broader product suite. Comparable as a broad incumbent in the same provider-facing digital health category ResApp plays in.

8Amwell
TypeBroad incumbent
Description

Amwell provides enterprise telehealth and virtual care platforms used by health systems and clinicians for urgent care, triage, and chronic care. Comparable broad incumbent serving similar clinician-assist use cases.

9Carbon Health
TypeDirect peer
Description

Carbon Health combines virtual triage, decision support, and in-person primary care using proprietary clinical software. Comparable as a digital-first clinician-assist platform with triage/decision support focus.

10Visby Medical
TypeEmerging player
Description

Visby Medical develops rapid diagnostic devices; less direct overlap but adjacent in clinician-facing diagnostic innovation, particularly respiratory infection testing. Regional/niche peer useful for diagnostic AI benchmarking.

Market position
Strengths2 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ResApp Health

Digital Health Diagnosticsresapphealth.com.au

ResApp Health is an Australia-based digital healthcare company developing solutions to assist doctors. Founded in 1990 in Perth, previously ASX-listed (RAP) and now delisted with a non-functional website; operated with a 1–10 person team.

What ResApp Health does

ResApp Health is an Australia-based digital healthcare company whose stated focus is developing software solutions to assist doctors, headquartered in Perth and previously listed on the Australian Securities Exchange under the ticker RAP. Founded in 1990 as a for-profit entity, it operated with a very lean team of 1–10 employees, suggesting a small, product-focused organization rather than a scaled commercial enterprise. The company's source material describes it in functional terms as a digital healthcare product developer, but does not include product-level descriptions, platform architecture, pricing, customer segments, or a defined go-to-market motion.

Capital activity is the most documented dimension of the company's operating history. ResApp closed three disclosed funding rounds: approximately AUD 3.09M in June 2015, AUD 9.74M in April 2016, and AUD 5.0M in February 2020 — a cumulative ~AUD 17.8M raise. No lead investors or round participants are identified in the source. Leadership comprises founder, CEO and Managing Director Tony Keating, Executive Director and Vice President Brian Leedman, and VP of Product and Technology Scott Savage.

The company's current operating footprint is markedly diminished. It is recorded as delisted from the ASX, and the corporate domain (resapphealth.com.au) returns a default cPanel error page indicating hosting or DNS issues rather than active content. No revenue figures, customer logos, product overviews, partnerships, regulatory milestones, M&A activity, or post-2020 strategic events are present in the source data. The information set is therefore better characterized as historical capital-record data rather than an active operating profile.

ResApp Health firmographics

Firmographics
Name
ResApp Health
Website
https://resapphealth.com.au
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
1–10 employees
Short description
ResApp Health is an Australia-based digital healthcare company developing solutions to assist doctors. Founded in 1990 in Perth, previously ASX-listed (RAP) and now delisted with a non-functional website; operated with a 1–10 person team.
Ownership category
akta.pro rank

ResApp Health industry classification

Industry
Product category
Digital Health Diagnostics
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro primary industry
Virtual Urgent Care & Triage Platforms (HLALABAB)
akta.pro secondary industry
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

  • Digital health diagnostics
  • Clinical decision support
  • Respiratory diagnostics
  • Healthcare mobile applications
  • Medical software platforms

Where ResApp Health is headquartered

Location

Headquarters

HQ city
Perth
HQ country
Australia
HQ region
Oceania

Markets served

ResApp Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations

ResApp Health product offering

Product offering

Core offering

ResApp Health is developing digital healthcare solutions to assist doctors. The company focuses on creating technology-based diagnostic and clinical support tools intended for use by medical professionals in patient care settings.

Differentiator

Problem solved

Functional benefit

Companies that use ResApp Health

Customer profile

Ideal customer profiles1 record

ResApp Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ResApp Health partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

ResApp Health competitors and assessment

Company assessment

Direct peers

  • Ada Health: Ada Health develops AI-powered symptom assessment and triage tools for both consumers and clinicians. Highly comparable to ResApp in targeting doctor-adjacent, symptom/triage decision support via software-only delivery.
  • Babylon Health: Babylon (acquired by eMed) built digital-first triage and virtual care tools used by clinicians and health systems. Comparable in providing software-led clinical decision support and triage to assist doctors, similar user workflow to ResApp's described offering.
  • K Health: K Health provides AI-driven clinical decision support and virtual primary care, with both consumer-facing triage and clinician-facing workflows. Direct peer in physician-assist digital health tooling.
  • Carbon Health: Carbon Health combines virtual triage, decision support, and in-person primary care using proprietary clinical software. Comparable as a digital-first clinician-assist platform with triage/decision support focus.

Emerging players

  • Biofourmis: Biofourmis focuses on AI-driven remote monitoring and predictive analytics for clinicians, particularly respiratory and cardiac conditions. Comparable in clinician-facing digital diagnostics using AI/ML on physiological signals.
  • Current Health (Best Buy Health): Current Health offers a remote patient monitoring and care management platform used by health systems to support clinicians with patient triage and decision-making. Comparable as a digital health platform augmenting clinical workflows.
  • Visby Medical: Visby Medical develops rapid diagnostic devices; less direct overlap but adjacent in clinician-facing diagnostic innovation, particularly respiratory infection testing. Regional/niche peer useful for diagnostic AI benchmarking.

Broad incumbents

  • Telehealth Medical (Doctor Anywhere / Doctor On Demand): Doctor On Demand (now part of Included Health) provides direct virtual urgent care and primary care platforms with clinician workflow tools. Comparable as a virtual triage / urgent care platform serving clinicians and patients.
  • Teladoc Health: Teladoc Health is the largest virtual care platform with provider-grade triage and decision support baked into its broader product suite. Comparable as a broad incumbent in the same provider-facing digital health category ResApp plays in.
  • Amwell: Amwell provides enterprise telehealth and virtual care platforms used by health systems and clinicians for urgent care, triage, and chronic care. Comparable broad incumbent serving similar clinician-assist use cases.

Market position

Strengths2 records

Weaknesses5 records

Competitive moat1 record

Key risks6 records

Key highlights4 records

Customer concentration

ResApp Health social profiles

Digital presence

ResApp Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ResApp Health leadership team

Management profile

Number of profiles

Profiles3 records

ResApp Health funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ResApp Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ResApp Health

What does ResApp Health do?

ResApp Health is developing digital healthcare solutions to assist doctors. The company focuses on creating technology-based diagnostic and clinical support tools intended for use by medical professionals in patient care settings.

When was ResApp Health founded?

ResApp Health was founded in 1990. It employs 1 to 10 people.

Where is ResApp Health based?

ResApp Health is headquartered in Perth, Australia, in the Oceania region.

Who are ResApp Health's main competitors?

Direct peers on record are Ada Health, Babylon Health, K Health and Carbon Health. Emerging players are Biofourmis, Current Health (Best Buy Health) and Visby Medical. Broad incumbents are Telehealth Medical (Doctor Anywhere / Doctor On Demand), Teladoc Health and Amwell.

Does ResApp Health have an API?

No public API is recorded for ResApp Health.

What industry is ResApp Health in?

ResApp Health's product category is Digital Health Diagnostics. Its primary akta.pro industry code is HLALABAB, Virtual Urgent Care & Triage Platforms, with a secondary code of HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comAsia Pacific Digital Therapeutics Market Trends, Industry Outlook | Key Companies - Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AGThe Asia Pacific digital therapeutics market is projected to grow at a CAGR of 23.30% from 2024 to 2031. Recent developments include CureApp launching a respiratory DTx platform in Japan, Omron introducing hypertension management tools in Japan and South Korea, and ResApp Health expanding respiratory and sleep solutions in Australia. China, Japan, South Korea, and India are leading the region.PR NewswireDigital Biomarkers Market Size, Share & Trends Analysis Report By Type, By Clinical Practice, By Therapeutic Area, By End-use, By Region And Segment Forecasts, 2022 - 2030The global digital biomarkers market is projected to reach USD 13,966.16 million by 2030, growing at a CAGR of 21.9% during the forecast period, driven by advancements in wearable and mobile technology and increasing adoption of remote data collection. Vocal digital biomarkers are emerging as a significant growth area, with companies developing voice-based monitoring solutions for early detection of mental and physical health conditions. Key market players are pursuing growth strategies including investments, partnerships, and acquisitions; notably, AstraZeneca invested USD 33.0 million in UK-based Huma and Pfizer acquired Australian startup ResApp in 2022.Startup DailyPharma giant Pfizer wins over telehealth startup ResApp Health with $179 million takeoverPfizer has completed the acquisition of ASX-listed telehealth startup ResApp Health for $179 million, following shareholder approval and regulatory clearance from the ACCC. The final deal price represents a significant increase from Pfizer's initial $100 million offer made in April 2022. As a result of the transaction, ResApp Health is now a wholly-owned subsidiary of Pfizer and has been delisted from the stock exchange.Business InsiderA health firm says it has developed an app that can detect COVID-19 when an infected person coughs into their phoneResApp Health developed a smartphone app that detects COVID-19 from cough sounds, claiming 92% accuracy in a trial of 741 people. Pfizer offered A$100 million to buy the company, pending regulatory approval. The app aims to reduce testing costs and improve security via biometric identification.ABCSmartphone app screening coughs for COVID-19 returns promising trial results, company saysAn Australian company, ResApp, has reported promising trial results for a smartphone app capable of detecting COVID-19 through cough sounds. The trial involving over 700 participants showed a detection rate of 92 percent for the virus, which the company claims exceeds the sensitivity of traditional rapid antigen tests. This technology could enhance access to testing, particularly in regions with limited resources for conventional testing methods.